References
- Manceau H, Chicha-Cattoir V, Puy H, et al. Fecal calprotectin in inflammatory bowel diseases: update and perspectives. Clin Chem Lab Med. 2017;55(4):474–483.
- Sipponen T, Kolho KL. Fecal calprotectin in diagnosis and clinical assessment of inflammatory bowel disease. Scand J Gastroenterol. 2015;50(1):74–80.
- Prell C, Nagel D, Freudenberg F, et al. Comparison of three tests for faecal calprotectin in children and young adults: a retrospective monocentric study. BMJ Open. 2014;4(5):e004558.
- Kristensen V, Malmstrøm GH, Skar V, et al. Clinical importance of faecal calprotectin variability in inflammatory bowel disease: intra-individual variability and standardisation of sampling procedure. Scand J Gastroenterol. 2016;51(5):548–555.
- Kolho KL, Alfthan H, Hamalainen E. Effect of bowel cleansing for colonoscopy on fecal calprotectin levels in pediatric patients. J Pediatr Gastroenterol Nutr. 2012;55(6):751–753.
- Peura S, Fall T, Almqvist C, et al. Normal values for calprotectin in stool samples of infants from the population-based longitudinal born into life study. Scand J Clin Lab Invest. 2018;78(1–2):120–124.
- Roca M, Rodriguez Varela A, Donat E, et al. Fecal calprotectin and eosinophil-derived neurotoxin in healthy children between 0 and 12 years. J Pediatr Gastroenterol Nutr. 2017;65:394–398.
- Joshi S, Lewis SJ, Creanor S, et al. Age-related faecal calprotectin, lactoferrin and tumour M2-PK concentrations in healthy volunteers. Ann Clin Biochem. 2010;47(3):259–263.
- Davidson F, Lock RJ. Paediatric reference ranges for faecal calprotectin: a UK study. Ann Clin Biochem. 2017;54(2):214–218.
- Kolho KL, Raivio T, Lindahl H, et al. Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease. Scand J Gastroenterol. 2006;41(6):720–725.
- Bunn SK, Bisset WM, Main MJ, et al. Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2001;33:14–22.
- Heida A, Park KT, van Rheenen PF. Clinical utility of fecal calprotectin monitoring in asymptomatic patients with inflammatory bowel disease: a systematic review and practical guide. Inflamm Bowel Dis. 2017;23(6):894–902.
- Haisma SM, Verkade HJ, Scheenstra R, et al. Time-to-reach target calprotectin level in newly diagnosed patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2019;69(4):466–473.
- Olafsdottir I, Nemeth A, Lörinc E, et al. Value of fecal calprotectin as a biomarker for juvenile polyps in children investigated with colonoscopy. J Pediatr Gastroenterol Nutr. 2016;62:43–46.
- Chen CC, Huang JL, Chang CJ, et al. Fecal calprotectin as a correlative marker in clinical severity of infectious diarrhea and usefulness in evaluating bacterial or viral pathogens in children. J Pediatr Gastroenterol Nutr. 2012;55:541–547.
- Fagerberg UL, Loof L, Merzoug RD, et al. Fecal calprotectin levels in healthy children studied with an improved assay. J Pediatr Gastroenterol Nutr. 2003;37(468):468–472.
- Oord T, Hornung N. Fecal calprotectin in healthy children. Scand J Clin Lab Invest. 2014;74(3):254–258.
- Song JY, Lee YM, Choi YJ, et al. Fecal calprotectin level in healthy children aged less than 4 years in South Korea. J Clin Lab Anal. 2017;31(6):e22113.
- Zhu Q, Li F, Wang J, et al. Fecal calprotectin in healthy children aged 1–4 years. PLoS One. 2016;11(3):e0150725.
- Virta LJ, Saarinen MM, Kolho KL. Inflammatory bowel disease incidence is on the continuous rise among all paediatric patients except for the very young: a nationwide registry-based study on 28-year follow-up. J Crohns Colitis. 2017;11(2):150–156.
- Olafsdottir E, Aksnes L, Fluge G, et al. Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children. Acta Paediatr. 2007;91(1):45–50.